PubMed:15630069 / 2341-2597 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCoin-entities

Id Subject Object Predicate Lexical cue db_id
1367 36-54 DiseaseOrPhenotypicFeature denotes insulin resistance MESH:D007333
1368 121-130 ChemicalEntity denotes clozapine MESH:D003024
1369 131-141 ChemicalEntity denotes olanzapine MESH:C076029
1370 142-153 ChemicalEntity denotes risperidone MESH:D018967
1371 156-165 ChemicalEntity denotes clozapine MESH:D003024
1372 169-180 ChemicalEntity denotes risperidone MESH:D018967
1373 206-216 ChemicalEntity denotes olanzapine MESH:C076029
1374 220-231 ChemicalEntity denotes risperidone MESH:D018967

LitCoin-sentences

Id Subject Object Predicate Lexical cue
T18 0-256 Sentence denotes The homeostasis model assessment of insulin resistance also differed significantly among groups (F(33) = 4.92; P = .01) (clozapine>olanzapine>risperidone) (clozapine vs risperidone, t(33) = 2.94; P = .006; olanzapine vs risperidone, t(33) = 2.42; P = .02).

LitCoin-GeneOrGeneProduct-v0

Id Subject Object Predicate Lexical cue
T28 36-43 GeneOrGeneProduct denotes insulin
T29 196-204 GeneOrGeneProduct denotes P = .006

LitCoin-GeneOrGeneProduct-v2

Id Subject Object Predicate Lexical cue
T16 36-43 GeneOrGeneProduct denotes insulin

LitCoin-Disease-MeSH

Id Subject Object Predicate Lexical cue originalLabel
T12 36-54 DiseaseOrPhenotypicFeature denotes insulin resistance D007333

LitCoin-MeSH-Disease-2

Id Subject Object Predicate Lexical cue ID:
T12 36-54 DiseaseOrPhenotypicFeature denotes insulin resistance D007333

LitCoin-MONDO_bioort2019

Id Subject Object Predicate Lexical cue #label
T10 36-54 DiseaseOrPhenotypicFeature denotes insulin resistance D007333

LitCoin-Chemical-MeSH-CHEBI

Id Subject Object Predicate Lexical cue ID:
T77 121-130 ChemicalEntity denotes clozapine D003024|http://purl.obolibrary.org/obo/CHEBI_3766
T79 131-141 ChemicalEntity denotes olanzapine D000077152|http://purl.obolibrary.org/obo/CHEBI_7735
T81 142-153 ChemicalEntity denotes risperidone D018967|http://purl.obolibrary.org/obo/CHEBI_8871
T83 156-165 ChemicalEntity denotes clozapine D003024|http://purl.obolibrary.org/obo/CHEBI_3766
T85 169-180 ChemicalEntity denotes risperidone D018967|http://purl.obolibrary.org/obo/CHEBI_8871
T87 206-216 ChemicalEntity denotes olanzapine D000077152|http://purl.obolibrary.org/obo/CHEBI_7735
T89 220-231 ChemicalEntity denotes risperidone D018967|http://purl.obolibrary.org/obo/CHEBI_8871

LitCoin-training-merged

Id Subject Object Predicate Lexical cue #label ID:
T89 220-231 ChemicalEntity denotes risperidone http://purl.obolibrary.org/obo/CHEBI_8871|D018967
T87 206-216 ChemicalEntity denotes olanzapine http://purl.obolibrary.org/obo/CHEBI_7735|D000077152
T85 169-180 ChemicalEntity denotes risperidone http://purl.obolibrary.org/obo/CHEBI_8871|D018967
T83 156-165 ChemicalEntity denotes clozapine http://purl.obolibrary.org/obo/CHEBI_3766|D003024
T81 142-153 ChemicalEntity denotes risperidone http://purl.obolibrary.org/obo/CHEBI_8871|D018967
T79 131-141 ChemicalEntity denotes olanzapine http://purl.obolibrary.org/obo/CHEBI_7735|D000077152
T77 121-130 ChemicalEntity denotes clozapine http://purl.obolibrary.org/obo/CHEBI_3766|D003024
T91158 36-54 DiseaseOrPhenotypicFeature denotes insulin resistance D007333